DELIVERY ORDER
Active75N98026F00001
Department of Health and Human Services › National Institutes of Health › NATIONAL INSTITUTES OF HEALTH OLAO
$2M
obligated · signed 3 months ago
TASK ORDER AWARD- PHASE I CLINICAL TRIALS FOR THE DEVELOPMENT OF NEUROTHERAPEUTICS- DTI-117 IN HEALTHY VOLUNTEERS/SAD AND MAD CT
Performance timeline
Start
Jun 29, 2026
End
Apr 28, 2027
with all options
Loading status
This contract is likely in the recompete window
Ends with all options: Apr 28, 2027
PPD DEVELOPMENT LP
Contract 75N98026F00001
UEI
ZANENSW6C665
Parent Company
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Capabilities & Certifications
Headquarters Location
Congressional District: 07
Current Obligation
$2,016,831
Base + Exercised Options
$2,016,831
Total Ceiling Value
$5,053,689
Contract Type
COST PLUS FIXED FEE
Multi-Year Contract
NO
NAICS
RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY)
PSC
HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
Place of Performance
Congressional District: 07
Awarding Agency
Top-tier agency
National Institutes of Health
Sub-tier agency
NATIONAL INSTITUTES OF HEALTH OLAO
Office
Funding Agency
Top-tier agency
National Institutes of Health
Sub-tier agency
NATIONAL INSTITUTES OF HEALTH NINDS
Office
Contract Vehicle
HHSN271201600005I
IDCDepartment of Health and Human Services
Award type: MULTIPLE AWARD
Solicitation procedures, competition exceptions, labor standards and account totals.